Search clinical trials for: Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System

Total 155 results

Medtronic Vascular

Completed

Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease

China
Russian Academy of Medical Sciences
Medtronic

Unknown

Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI (ZES for STEMI)

ST Elevation Myocardial Infarction, Multivessel Coronary Artery Disease

Russian Federation
Medtronic Vascular

Completed

RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)

Coronary Artery Disease

United States, Belgium, France, Slovakia
Shanghai Jiao Tong University School of Medicine

Completed

Efficacy and Safety of RESOLUTE Zotarolimus-Eluting Stent in Treatment of Chinese Diabetic Coronary Lesions (RESOLUTE-DM)

Coronary Artery Disease | Diabetes

China
Medtronic Vascular

Completed

The Medtronic RESOLUTE US Clinical Trial (R-US)

Coronary Artery Disease

United States
Medtronic Vascular
Medtronic Bakken Research Center

Completed

RESOLUTE International Registry: Evaluation of the Resolute Zotarolimus-Eluting Stent System in a 'Real-World' Patient Population (R-Int)

Cardiovascular Diseases | Coronary Artery Disease

Germany
Medtronic Vascular

Completed

China Resolute Integrity 34/38 mm Study

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Stenotic Coronary Lesion

China
Medtronic Vascular

Active, not recruiting

RESOLUTE ONYX China Single Arm Study

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Stenotic Coronary Lesion

China
Medtronic Vascular

Active, not recruiting

RESOLUTE ONYX China RCT Study

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Stenotic Coronary Lesion

China
Medtronic Vascular

Completed

A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients (Onyx ONE)

Coronary Artery Disease

Korea, Republic of, Spain, Australia, Hong Kong, United Kingdom, Singapore, Thailand, Belgium, New Zealand, Sweden, France, Switzerland, Netherlands, Italy, Slovakia, Lithuania, Austria, Malaysia, Bulgaria, Ireland, Latvia, Norway, ...
Seoul National University Hospital
Medtronic

Unknown

Effect and Efficacy of Onyx™, Zotarolimus-eluting Stent for Coronary Atherosclerosis (HOST-ONYX)

Myocardial Infarction | Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome

Korea, Republic of
Andres Iñiguez Romo, MD, PhD

Completed

Randomized Trial of Coronary Angioplasty for de Novo Lesions in sMall vesSElS With Drug Eluting Balloon. (RAMSES)

Coronary Disease

Spain
Fujian Medical University
Jetmed（Beijing）Co.,Ltd.

Completed

Comparison of Double Kissing Culotte Stenting With Double Kissing Crush Stenting for True Bifurcation Lesions

Coronary Heart Disease

China
Aarhus University Hospital Skejby
Medtronic Cardiovascular; Biosensors International

Completed

SORT-OUT VI - Randomized Clinical Comparison of Biomatrix Flex® and Resolute Integrity® (SO VI)

Coronary Artery Disease | Angina Pectoris

Denmark
Medtronic Vascular

Completed

A Single Arm Trial With Resolute Onyx in ONE-Month DAPT for High-Bleeding Risk Patients Who Are Considered One-Month Clear (Onyx ONE Clear) (Onyx ONE Clear)

Coronary Artery Disease

United States
Medtronic Vascular
Medtronic Bakken Research Center

Completed

Randomized, Two-arm, Non-inferiority Study Comparing Endeavor-Resolute Stent With Abbot Xience-V Stent (RESOLUTE-AC)

Coronary Artery Disease

Switzerland
Medtronic Vascular

Completed

PROTECT Continued Access Post Marketing Surveillance Trial (PROTECT-CA)

Coronary Artery Disease, Autosomal Dominant, 1

United States
Medtronic Vascular
Medtronic Japan Co., Ltd.

Completed

RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent (RJ)

Myocardial Ischemia | Cardiovascular Diseases | Coronary Artery Disease | Arterial Occlusive Diseases

Japan
Medtronic Vascular

Completed

RESOLUTE China RCT (R-China RCT)

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Stenotic Coronary Lesion

China
Medtronic Vascular

Completed

Endeavor Zotarolimus - Eluting Stent in the Treatment Lesions in Small Native Coronary Arteries. (ENDEAVORSVS)

Coronary Artery Disease

United States
Medtronic Bakken Research Center

Completed

E-Five Registry: A World-Wide Registry With The Endeavor Zotarolimus Eluting Coronary Stent (eFive)

Coronary Artery Disease
Yonsei University
Medtronic Vascular

Completed

Comparison of Neointimal Coverage Between Zotarolimus Eluting Stent and Everolimus Eluting Stent (COVER OCT)

Coronary Artery Disease

Korea, Republic of
National Taiwan University Hospital

Unknown

Imaging and Interventional Study for Erectile Dysfunction and Lower Urinary Tract Symptoms (PERFECT)

Lower Urinary Tract Symptoms | Peripheral Arterial Disease | Erectile Dysfunction

Taiwan
Keimyung University Dongsan Medical Center

Unknown

Late Stent Strut Apposition and Coverage After Drug-Eluting Stent Implantation by OCT in Patients With AMI

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive Diseases

Korea, Republic of
Harbin Medical University
The First Affiliated Hospital with Nanjing Medical University; Peking University... and other collaborators

Active, not recruiting

Safety and Efficacy of Drug-Coated Balloon for De-novo Lesions in Patients With Acute Coronary Syndromes (DCB-ACS) (DCB-ACS)

Coronary Artery Disease | De Novo Stenosis | Clinical Trial | Acute Coronary Syndromes | ACS | DCB | Drug-Coated Balloon

China
Foundation of Cardiovascular Research and Education...

Completed

DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity in an All Comers Population (DUTCH PEERS)

Myocardial Infarction | Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Angina, Unstable | Coronary Stenosis | Coronary Restenosis

Netherlands
424 General Military Hospital

Completed

Serum Irisin in Myocardial Infraction and Following Percutaneous Coronary Intevention (IRICARDIO)

Myocardial Infarction | Coronary Artery Disease

Greece
Yonsei University
Medtronic; Severance Hospital

Recruiting

Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT (ONYSOVER)

Coronary Artery Disease | Optical Coherence Tomography | Stent

Korea, Republic of
Deutsches Herzzentrum Muenchen
Technical University of Munich

Completed

Drug-eluting Stents to Treat Unprotected Coronary Left Main Disease (LEFT-MAIN-2)

Coronary Disease

Germany, Italy
Thorax Centrum Twente

Unknown

DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity (DUTCHPEERS)

Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Unstable Angina Pectoris | Coronary Stenosis | Coronary Restenosis

Netherlands
A.O. Ospedale Papa Giovanni XXIII
Medtronic; Case Western Reserve University

Completed

Vessel Wall Response of the Zotarolimus Drug-eluting Stent Implanted in AMI Assessed by Optical Coherence Tomography (OCTAMI)

Acute Myocardial Infarction

Italy
Atrium Medical Corporation

Terminated

The Clinical Evaluation of the Cinatra™ Corolimus-Eluting Coronary Stent in De Novo Lesions in Native Coronary Arteries (VANTAGE-1)

Coronary Artery Disease

New Zealand
Cook Group Incorporated

Terminated

Evaluation of the GTX™ 5126 DES Coronary Stent System in the Treatment of Patients With a Lesion in the Coronary Artery

Coronary Artery Disease

Germany
Medtronic Vascular

Completed

RESOLUTE Japan SVS: The Clinical Evaluation of the MDT-4107 DES in the Treatment of De Novo Lesions in Small Diameter Native Coronary Arteries (RJ-SVS)

Myocardial Ischemia | Cardiovascular Diseases | Coronary Artery Disease | Arterial Occlusive Diseases

Japan
Chonbuk National University Hospital

Unknown

COmparison of Xience PrimE Versus REsolute Integrity in Diabetes or Small Vessel Disease (COPERES)

Angioplasty, Balloon, Coronary

Korea, Republic of
Foundation of Cardiovascular Research and Education...

Completed

The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting Stent Study in Twente (TWENTE)

Coronary Artery Disease | Angina Pectoris | Unstable Angina Pectoris | Coronary Stenosis | Coronary Restenosis

Netherlands
University Hospital Heidelberg

Completed

Procedural Advantages of a Novel Drug-Eluting Coronary Stent

Coronary Artery Disease
Medtronic Bakken Research Center

Completed

Assessment of Clinical Performance and Costs of the Endeavor Resolute Stent "in Real Life" in Spain. (REDES)

Coronary Artery Disease

Spain
Emory University
Medtronic

Completed

Wall Shear Stress and Neointimal Healing Following PCI in Angulated Coronary Vessels (SHEAR-STENT)

Coronary Artery Disease

Korea, Republic of, Serbia, United States, China, Japan, Latvia, Spain
Medtronic Vascular

Completed

RESOLUTE ONYX Post-Approval Study (ONYX PAS)

Coronary Artery Disease

United States, Belgium, France, Slovakia
Yonsei University
Gangwon Cardiovascular Health Research Institute

Terminated

BES, EES, and ZES-R in Real World Practice (CHOICE)

Coronary Artery Disease

Korea, Republic of
Seoul National University Bundang Hospital
Korea University; Inje University; SMG-SNU Boramae Medical Center; Kyung Hee University... and other collaborators

Completed

Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent (ORIENT)

Coronary Artery Disease | Coronary Heart Disease | Stable Angina | ST-segment Elevation Myocardial Infarction | Unstable Angina | Non-ST-segment Elevation Myocardial Infarction

Korea, Republic of
Yonsei University

Completed

Intravascular ULTrasound Guided Versus Conventional Angiography Guided Strategy to Deploy Zotarolimus and Everolimus Eluting Third Generation Stents in the Long Coronary Artery Lesions: ULTRA-ZET Trial

Coronary Artery Disease

Korea, Republic of
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Non-inferiority Clinical Trial to Compare the Safety and Performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions (MeRethonRCT)

Coronary Artery Disease
DK Medical Technology (Suzhou) Co., Ltd.
Core Medical (Beijing) Co., Ltd.

Active, not recruiting

A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary Small Vessel Disease

Coronary Small Vessel Disease

China
Deutsches Herzzentrum Muenchen

Unknown

Test Safety and Efficacy of Zotarolimus- and Everolimus-Eluting Stents (ZES/EES) Assessed by Optical Coherence Tomography (ZES/EES-OCT)

Coronary Heart Disease

Germany
Abbott Medical Devices

Completed

SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System (SPIRIT II)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Spain, Denmark, Germany, France, Austria, Belgium, India, Italy, New Zealand, Poland, South Africa, Switzerland
Abbott Medical Devices

Completed

SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System

Coronary Artery Disease

United States
Yonsei University

Unknown

Impact of Intravascular Ultrasound(IVUS)-Guided Chronic Total Occlusion Intervention With Drug-eluting Stents (CTO)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
Abbott; CardioVascular Research Foundation, Korea

Terminated

LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery)

Coronary Artery Disease

Korea, Republic of

Search clinical trials for: Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations